Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
123M
-
Number of holders
-
138
-
Total 13F shares, excl. options
-
67.9M
-
Shares change
-
+3.2M
-
Total reported value, excl. options
-
$202M
-
Value change
-
+$814K
-
Put/Call ratio
-
0.58
-
Number of buys
-
64
-
Number of sells
-
-68
-
Price
-
$2.97
Significant Holders of CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) as of Q3 2020
165 filings reported holding CPRX - CATALYST PHARMACEUTICALS, INC. - COMMON STOCK as of Q3 2020.
CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) has 138 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 67.9M shares
of 123M outstanding shares and own 55.1% of the company stock.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (10M shares), STATE STREET CORP (7.63M shares), BlackRock Inc. (7.47M shares), VANGUARD GROUP INC (4.95M shares), MANGROVE PARTNERS (3.03M shares), MORGAN STANLEY (2.78M shares), GOLDMAN SACHS GROUP INC (2.53M shares), PRUDENTIAL FINANCIAL INC (2.45M shares), ROYCE & ASSOCIATES LP (1.78M shares), and LSV ASSET MANAGEMENT (1.59M shares).
This table shows the top 138 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.